Skip to main content

Clinical Utility of Plasma Aβ42/40 Ratio by LC-MS/MS in Alzheimer’s Disease Assessment

Clinical Utility of Plasma Aβ42/40 Ratio by LC-MS/MS in Alzheimer’s Disease Assessment

Authors: Weber DM, Taylor SW, Lagier RJ, Kim JC, Goldman SM, Clarke NJ, Vaillancourt DE, Duara R, McFarland KN, Wang W-E, Golde TE, Racke MK

Citation: Front Neurol. 2024;15:1364658. doi:10.3389/fneur.2024.1364658

Specialties: Neurology

Date:
Mar 24, 2024
Citation: Front Neurol. 2024;15:1364658. doi:10.3389/fneur.2024.1364658

Key Summary